Key result
MYH6 mutations were identified in patients with isolated congenital heart defects, with specific variants significantly disrupting or enhancing myofibril formation in vitro.
Observational (n=470)
Answers are grounded in this paper and cite their sources.
Functional variants of MYH6 are associated with a wide spectrum of sporadic congenital heart defects, potentially through disruption of myofibril formation.
Congenital heart defects (CHD) are collectively the most common form of congenital malformation. Studies of human cases and animal models have revealed that mutations in several genes are responsible for both familial and sporadic forms of CHD. We have previously shown that a mutation in MYH6 can cause an autosomal dominant form of atrial septal defect (ASD), whereas others have identified mutations of the same gene in patients with hypertrophic and dilated cardiomyopathy. In the present study, we report a mutation analysis of MYH6 in patients with a wide spectrum of sporadic CHD. The mutation analysis of MYH6 was performed in DNA samples from 470 cases of isolated CHD using denaturing high-performance liquid chromatography and sequence analysis to detect point mutations and small deletions or insertions, and multiplex amplifiable probe hybridization to detect partial or complete copy number variations. One non-sense mutation, one splicing site mutation and seven non-synonymous coding mutations were identified. Transfection of plasmids encoding mutant and non-mutant green fluorescent protein-MYH6 fusion proteins in mouse myoblasts revealed that the mutations A230P and A1366D significantly disrupt myofibril formation, whereas the H252Q mutation significantly enhances myofibril assembly in comparison with the non-mutant protein. Our data indicate that functional variants of MYH6 are associated with cardiac malformations in addition to ASD and provide a novel potential mechanism. Such phenotypic heterogeneity has been observed in other genes mutated in CHD.
No takes yet. Share an insight, caveat, or question.
Granados-Riveron et al. (2010) conducted an observational in isolated congenital heart defects (n=470). MYH6 mutations vs. non-mutant MYH6 was evaluated on Identification of MYH6 mutations and their effect on myofibril formation. MYH6 mutations were identified in patients with isolated congenital heart defects, with specific variants significantly disrupting or enhancing myofibril formation in vitro.
Synapse has enriched 10 related papers. Consider them for comparative context: